Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 2/20 | 0.35 |
| ▸ | CASP7 | P55210 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL308272 | 0.73 | HTR6 (0.40) | KMT2AALDH1A1HPGDTSHRKDM4E | |
| SCHEMBL7155040 | 0.71 | MEN1 (0.34) | MEN1KMT2ATP53HSD17B10ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8159133 | 0.70 | MEN1 (0.31) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6554714 | 0.70 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL787473 | 0.69 | MEN1 (0.37) | MEN1KMT2ATP53HSD17B10ALDH1A1 | |
| SCHEMBL7931392 | 0.68 | MEN1 (0.35) | MEN1KMT2ATP53HSD17B10ALDH1A1 | |
| SCHEMBL1655232 | 0.67 | MEN1 (0.46) | MEN1KMT2ATP53HSD17B10ALDH1A1 | |
| SCHEMBL30924248 | 0.67 | MEN1 (0.46) | MEN1KMT2ATP53HSD17B10ALDH1A1 | |
| SCHEMBL5917329 | 0.67 | MEN1 (0.35) | MEN1KMT2AMAPTGAA | |
| SCHEMBL4859806 | 0.67 | MEN1 (0.38) | MEN1KMT2ATP53HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3068405-B1 | PYRROLO [1,2,F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | GILEAD SCIENCES INC (US) | 2019-05-01 | — | — | EP | claimed |
| EP-2646411-B1 | PREPARATION OF PET PRECURSOR | BLUE EARTH DIAGNOSTICS LTD (GB) | 2017-08-16 | — | — | EP | claimed |
| US-9493469-B2 | Piperidine inhibitors of Janus kinase 3 | AUSPEX PHARMACEUTICALS, INC. (US) | 2016-11-15 | — | — | US | claimed |
| US-8093354-B2 | Process for preparing glycopeptide phosphonate derivatives | THERAVANCE, INC. (US) | 2012-01-10 | — | — | US | claimed |
| US-20110060122-A1 | PROCESS FOR PREPARING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES | THERAVANCE, INC. (US) | 2011-03-10 | — | — | US | claimed |
| US-20080227963-A1 | Process for preparing glycopeptide phosphonate derivatives | CUMBERLAND PHARMACEUTICALS INC. | 2008-09-18 | — | — | US | claimed |
| EP-1418933-B1 | PROCESS FOR PREPARING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES | THERAVANCE INC (US) | 2007-05-02 | — | — | EP | claimed |
| EP-1419174-B1 | PROCESS FOR PREPARING GLYCOPEPTIDE DERIVATIVES | THERAVANCE INC (US) | 2007-04-18 | — | — | EP | claimed |
| US-20060264607-A1 | Process for preparing glycopeptide phosphonate derivatives | CUMBERLAND PHARMACEUTICALS INC. | 2006-11-23 | — | — | US | claimed |
| US-7015305-B2 | Process for preparing glycopeptide derivatives | THERAVANCE, INC. (US) | 2006-03-21 | — | — | US | claimed |
| US-6979723-B2 | Process for preparing glycopeptide phosphonate derivatives | THERAVANCE, INC. (US) | 2005-12-27 | — | — | US | claimed |
| US-20030069391-A1 | Process for preparing glycopeptide phosphonate derivatives | CUMBERLAND PHARMACEUTICALS INC. | 2003-04-10 | — | — | US | claimed |
| US-20030045457-A1 | Process for preparing glycopeptide derivatives | CUMBERLAND PHARMACEUTICALS INC. | 2003-03-06 | — | — | US | claimed |
| US-11999757-B2 | Synthesis of boronate ester derivatives and uses thereof | MELINTA SUBSIDIARY CORP. (US) | 2024-06-04 | — | — | US | disclosed |
| CN-117986153-A | Ionizable cationic lipid compound, and preparation method and application thereof | 晟迪生物医药(苏州)有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-114085243-B | Pyrrolo [1,2-f ] [1,2,4] triazines useful for the treatment of respiratory syncytial virus infection | 吉利德科学公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-1289999-B1 | ANTITUMORAL ANALOGS OF ET-743 | PHARMA MAR SA (ES) | 2004-11-17 | — | — | EP | disclosed |
| US-20030119021-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-06-26 | — | — | US | disclosed |
| US-20030069391-A1 | Process for preparing glycopeptide phosphonate derivatives | CUMBERLAND PHARMACEUTICALS INC. | 2003-04-10 | — | — | US | disclosed |
| US-20030045457-A1 | Process for preparing glycopeptide derivatives | CUMBERLAND PHARMACEUTICALS INC. | 2003-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045457-A1 | Process for preparing glycopeptide derivatives | GYPA, VIP, OGT | MEN1 3165/4885KMT2A 4121/4885TP53 3209/4885 |
| US-20060264607-A1 | Process for preparing glycopeptide phosphonate derivatives | PGLS, GYPA, PAG1 | MEN1 2435/4885KMT2A 4252/4885TP53 1881/4885 |
| US-20080227963-A1 | Process for preparing glycopeptide phosphonate derivatives | PGLS, GYPA, PAG1 | MEN1 2435/4885KMT2A 4252/4885TP53 1881/4885 |
| US-20110060122-A1 | PROCESS FOR PREPARING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES | PGLS, GYPA, PAG1 | MEN1 2435/4885KMT2A 4252/4885TP53 1881/4885 |
| US-11999757-B2 | Synthesis of boronate ester derivatives and uses thereof | ADH5, ADH1A, ADH7 | MEN1 3249/4885KMT2A 3000/4885TP53 4688/4885 |
| US-20030069391-A1 | Process for preparing glycopeptide phosphonate derivatives | PGLS, GYPA, PAG1 | MEN1 2435/4885KMT2A 4252/4885TP53 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.